Article Name Clinical & Diagnostic
Collaboration to provide hospitals with a comprehensive offering across imaging and treatment for cancer patients requiring radiation therapy
07th July, 2023
Genesis MedTech, a leading medical device company, announced that its ArtiSential™, a revolutionary series of articulating laparoscopic instruments, has successfully obtained approval from the China's National Medical Products Administration (NMPA) for market release.
07th July, 2023
Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo® Heart Failure. HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF). HCPCS code C9786 can now be used for billing artificial intelligence to aid the detection of Heart Failure with Preserved Ejection Fraction (HFpEF).
06th July, 2023
The wearable ultrasound imaging solution combines the wireless freedom of Clarius ultrasound with the security of the ProbeFix Dynamic, enabling limitless research opportunities of bodies in motion.
06th July, 2023
MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, announced its ultra-high-throughput genetic sequencer DNBSEQ-T7 received the medical device registration certificate from the Korea Ministry of Food and Drug Safety (MFDS).
06th July, 2023
Inaugurated by the Minister for Finance, Health, Medical & Family Welfare, Government of Telangana
05th July, 2023
Medtronic is excited by the updated European Hypertension Society (ESH) guidelines that highlight the role of renal denervation (RDN) as part of the hypertension care pathway. The guidelines were announced at the ESH 32nd Annual Meeting and simultaneously published in the Journal of Hypertension.
04th July, 2023
Recent study conducted by Seoul National University Hospital provides strong evidence that high-accuracy AI model improves radiologists' chest X-ray analysis performance
04th July, 2023
At no additional cost to patients
03rd July, 2023
Group Management Services (GMS), a leading professional employer organization (PEO) headquartered in Richfield, Ohio, is pleased to announce its partnership with Lumina Imaging and Diagnostics. This collaboration revolutionizes the health care landscape for GMS clients and their employees throughout Northeast Ohio.
03rd July, 2023
To enhance awareness around the importance of safety protocols, practices, and technologies to deliver optimum Patient and clinical outcomes as well as enable knowledge-sharing of best practices around this key area, BD (Becton, Dickinson, and Company) recently organized the ‘Pledge for Safety' - Clinical Leaders Forum.
30th June, 2023
Building interdisciplinary, multisectoral partnerships to unite CVD action across borders
28th June, 2023
System Allows Conversion to Reverse Shoulder Replacement Prosthesis
28th June, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that its Elecsys® beta-Amyloid (1-42) CSF II (Abeta42) and Elecsys® Total-Tau CSF assays (tTau) have received U.S. Food and Drug Administration (FDA) 510(k) clearance. The Elecsys AD CSF Abeta42 and tTau assays (used as a tTau/Abeta42 ratio) measure two biomarkers of Alzheimer's pathology, beta-amyloid and tau proteins, in adults ages 55 and older being evaluated for the disease.
28th June, 2023
INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture ("IVC") procedure it enables, today announced it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to expand the labeling on the INVOcell device and its indication for use to provide for a 5-day incubation period. The data supporting the expanded 5-day incubation clearance demonstrated improved patient outcomes.
28th June, 2023
Next-generation FDA-cleared medical device brings non-invasive heart and lung disease detection to healthcare professionals at the point of care
28th June, 2023
Manipal Hospitals and Queen Elizabeth University Hospital – Interventional Radiology departments ink partnership
17th April, 2023
State-of-the-art facility span over 2,32,000 square feet
17th April, 2023
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer